The anthracycline antibiotics: antitumor drugs that alter chromatin structure.
about
Crystal structure and functional analysis of tetracenomycin ARO/CYC: Implications for cyclization specificity of aromatic polyketidesStructural and Biochemical Characterization of ZhuI Aromatase/Cyclase from the R1128 Polyketide PathwayProbing the dynamics of doxorubicin-DNA intercalation during the initial activation of apoptosis by fluorescence lifetime imaging microscopy (FLIM)PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cellsAssay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes.Anthracenedione derivatives as anticancer agents isolated from secondary metabolites of the mangrove endophytic fungiDNA repair and personalized breast cancer therapyCucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cellsAnthracycline cardiotoxicity in childhood.Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12.Modeling and Analysis of Intercalant Effects on Circular DNA ConformationiNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells.Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicity.A new anthracycline-type metabolite from Streptomyces sp. NEAU-L3.Reversal of human multi-drug resistance leukaemic cells by stemofoline derivatives via inhibition of P-glycoprotein function.ABT-737, Synergistically Enhances Daunorubicin-Mediated Apoptosis in Acute Myeloid Leukemia Cell Lines.Cathepsin B cleavable novel prodrug Ac-Phe-Lys-PABC-ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis: an experimental study.Late morfofunctional alterations of the Sertoli cell caused by doxorubicin administered to prepubertal rats.Nucleosome stability measured in situ by automated quantitative imaging.Bioactivity-guided genome mining reveals the lomaiviticin biosynthetic gene cluster in Salinispora tropicaCharacterization of rhodosaminyl transfer by the AknS/AknT glycosylation complex and its use in reconstituting the biosynthetic pathway of aclacinomycin A.Suppression of Pu.1 function results in expanded myelopoiesis in zebrafish.Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by Doxorubicin.Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia.The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy.Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment: sCD40L-caspase 3 chimeric protein for treating B-cell malignancies.High-Content Screening Comparison of Cancer Drug Accumulation and Distribution in Two-Dimensional and Three-Dimensional Culture Models of Head and Neck Cancer.Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia.Synergistic anticancer effects of lectin and doxorubicin in breast cancer cells.Doxorubicin kinetics and effects on lung cancer cell lines using in vitro Raman micro-spectroscopy: binding signatures, drug resistance and DNA repair.Studies of Adriamycin Binding to Histone H1 by Resonant Mirror Biosensor and Fluorescence Spectroscopy
P2860
Q27650227-32F1FDF8-1AEC-4BE1-9C31-7589B9DC3117Q27672158-778B0806-8A19-4152-BF94-449ED7EE4E4AQ28483863-E81F8DF9-2CE9-465E-B158-49A091AFB91EQ28484680-2A9FF034-AEBB-4BD8-9511-07194E355F50Q30398275-436E1B9F-3C45-43CD-B05F-5E912490DB2BQ33837067-65C348B7-FFB9-45BD-B7ED-E907257EFCFCQ34234936-99088B69-724A-4BD4-93BF-080D2122245CQ36109261-F64EB325-A2D1-4473-98D4-74A16081856CQ37165394-4E7487DF-180B-4FBF-B8DF-15F2C4C5DB29Q37382513-BEC7CBBF-565F-4E65-B3CE-3C585AEB7221Q37418295-98AACA6D-5C53-40CE-BF74-4211C5E0A6F3Q37448441-47F41FB2-8265-4FCF-BCA7-EF859B88BD80Q37699783-17B53340-1ED0-49CD-841D-48D5968636BBQ38622956-9669F7DE-58F7-496E-92AF-B15803C66FF4Q38952318-AEE8D016-B840-4BB1-86B4-D6A4E538FB72Q39025514-4899936A-38E1-438C-ABB2-E294EE5F9207Q39456682-0E39F596-F347-4950-B9BD-726BD718B6F0Q41564520-E6A5959D-D072-418A-B3E1-28120AA3CDFDQ42371838-9294B487-4EFC-4013-A2B8-043251B41CEEQ42575196-3999E06C-FA14-405F-9604-9C8490F03AF8Q43245428-8051AEAE-02A6-44DA-97AE-76B71D652000Q43418051-8493B35E-FE83-412A-BDC9-20BEE53F654FQ46249034-D08A1B47-2712-4337-84B5-A442D92EBE00Q47429450-E583EAC1-4C34-422E-A033-B0F1E0BFAA3DQ48214395-13046F26-3F40-4767-9492-B6013DD29E07Q48784822-841D227D-A253-4C8D-BD88-394BF0D15C7EQ50032174-CEA28250-2BFD-47E7-8331-4E1795AD4195Q51458897-7CDBEC61-E632-484D-ACF4-63491AD8FB02Q51731440-309A9E76-55E2-4001-B0AF-C0A05647F956Q53735791-2A4EAE07-C29A-49A8-8E06-DD0F6756B548Q58280111-F24C7DE6-54B0-4A16-B380-B6A81CF41AA4
P2860
The anthracycline antibiotics: antitumor drugs that alter chromatin structure.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The anthracycline antibiotics: antitumor drugs that alter chromatin structure.
@ast
The anthracycline antibiotics: antitumor drugs that alter chromatin structure.
@en
type
label
The anthracycline antibiotics: antitumor drugs that alter chromatin structure.
@ast
The anthracycline antibiotics: antitumor drugs that alter chromatin structure.
@en
prefLabel
The anthracycline antibiotics: antitumor drugs that alter chromatin structure.
@ast
The anthracycline antibiotics: antitumor drugs that alter chromatin structure.
@en
P2093
P2860
P356
P1433
P1476
The anthracycline antibiotics: antitumor drugs that alter chromatin structure.
@en
P2093
Azra Rabbani
Juan Ausió
Ron M Finn
P2860
P356
10.1002/BIES.20160
P407
P577
2005-01-01T00:00:00Z